Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Alpine Immune Sciences Inc
(NQ:
ALPN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alpine Immune Sciences Inc
< Previous
1
2
3
4
5
6
7
Next >
Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity'
April 11, 2024
The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have significant implications for the near-term trend in cons
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 11, 2024
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via
InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
April 11, 2024
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant...
Via
Benzinga
Navigating 8 Analyst Ratings For Alpine Immune Sciences
April 09, 2024
Via
Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/19
March 19, 2024
Via
Investor Brand Network
Evaluating Alpine Immune Sciences: Insights From 6 Financial Analysts
March 19, 2024
Via
Benzinga
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
April 10, 2024
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8% at...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders
April 10, 2024
From
Halper Sadeh LLC
Via
Business Wire
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
April 10, 2024
The companies expect the deal to close later this quarter.
Via
Investor's Business Daily
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy
April 10, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Recap: Alpine Immune Sciences Q4 Earnings
March 18, 2024
Via
Benzinga
Preview: Alpine Immune Sciences's Earnings
March 15, 2024
Via
Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/8
March 08, 2024
Via
Investor Brand Network
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
April 10, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?
April 10, 2024
Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities.
Via
Benzinga
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
April 04, 2024
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 2/29
February 29, 2024
Via
Investor Brand Network
In-Depth Examination Of 6 Analyst Recommendations For Alpine Immune Sciences
January 26, 2024
Via
Benzinga
Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024
April 01, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
March 21, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
March 20, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Via
Benzinga
Alpine Immune Sciences Analysts Boost Their Forecasts After Q4 Earnings
March 19, 2024
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) reported better-than-expected fourth-quarter financial results.
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q4 2023
March 18, 2024
ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
March 18, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Earnings Scheduled For March 18, 2024
March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
February 26, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
February 01, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.